This paper is in the following e-collection/theme issue:

Immunology, Allergy, Rheumatology (78) Home Care (159) Asthma Education and Self-Management in Childhood and Adolescence (68)

Published on in Vol 9, No 2 (2020): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17863, first published .
Health-Related Effects of Home Nebulization With Glycopyrronium on Difficult-to-Treat Asthma: Post-Hoc Analyses of an Observational Study

Health-Related Effects of Home Nebulization With Glycopyrronium on Difficult-to-Treat Asthma: Post-Hoc Analyses of an Observational Study

Health-Related Effects of Home Nebulization With Glycopyrronium on Difficult-to-Treat Asthma: Post-Hoc Analyses of an Observational Study

Authors of this article:

Deepak Talwar1 Author Orcid Image ;   Salil Bendre2 Author Orcid Image
Article Authors Cited by (4) Tweetations (1) Metrics

Journals

  1. Albertson T, Pugashetti J, Chau-Etchepare F, Chenoweth J, Murin S. Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 2020;21(16):1991 View
  2. Wei W, Chen W, He N. HDAC4 induces the development of asthma by increasing Slug-upregulated CXCL12 expression through KLF5 deacetylation. Journal of Translational Medicine 2021;19(1) View
  3. Mathis B, Kusumoto M, Zaboronok A, Hiramatsu Y. Packaging and Delivery of Asthma Therapeutics. Pharmaceutics 2021;14(1):92 View
  4. Pelaia C, Crimi C, Crimi N, Ricciardi L, Scichilone N, Valenti G, Bonavita O, Andaloro S, Morini P, Rizzi A, Pelaia G. Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma. Expert Review of Respiratory Medicine 2022;16(2):183 View